跳至主要内容
临床试验/NCT01451229
NCT01451229已完成1 期

An Open-Label, Single-dose Administration Study of the Pharmacokinetics and Pharmacodynamics of Higenamine, Administered Intravenously Injection to Healthy Chinese Subjects

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2009年6月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
The maximum observed plasma concentration

研究概览

简要总结

The purpose of this study is to assess the pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must meet all the following inclusion criteria to be eligible to participate in this study:
  • Chinese healthy adult males, female subjects (either gender the proportion of not less than 1 / 3).
  • Age: 19 to 45 (including 19, 45) years old.
  • Male body weight ≥ 50kg, female body weight ≥ 45kg, and body mass index within the normal range (weight (kg) / height 2 (m2) = 18-25).
  • Informed consent form is obtained.

排除标准

  • Subjects will be excluded from entry if any of the criteria listed below are met:
  • Presence or history of any disorder of cardiovascular system, respiratory system, digestive system, urogenital system, endocrine system, allergy / immune system, blood system, nervous / mental system, musculoskeletal system, skin diseases.
  • History of any drug hypersensitivity.
  • Female urine pregnancy test was positive.
  • Positive serologic findings for human immunodeficiency virus (HIV) antibodies, hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and/or hepatitis C virus (HCV) antibodies.
  • Acute disease state or infection associated with prescription drugs within 1 month before study day
  • Taking any drugs, including over-the-counter drugs and herbal supplements within 7 days before study day
  • History of alcohol abuse (consuming greater than 14 glasses of alcoholic beverages each week, 1 glass is approximately equivalent to: beer 284 mL, wine 125 mL, or distilled spirits [25 mL).
  • History of drug abuse.
  • Smoker or subjects quitting smoking less than 1 month before study day
  • Participating other trials within 1 month before study day
  • Donating blood (> 400 mL) within 1 month before study day
  • During screening, alcohol breath test result > 0.
  • Systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg.
  • Heart rate was lower than 45 beats per minute (bpm) and/or higher than 90 bpm during rest.
  • The investigator thought the subjects might not be able to complete the study or comply with the requirements of the study (due to management reasons or other reasons).

结局指标

主要结局

The maximum observed plasma concentration

时间窗: predose and at 1, 3, 5, 7, 9, 12, 15, 20, 30, 60 and 90 minutes postdose

area under the concentration-time curve

时间窗: predose and at 1, 3, 5, 7, 9, 12, 15, 20, 30, 60 and 90 minutes postdose

clearance

时间窗: predose and at 1, 3, 5, 7, 9, 12, 15, 20, 30, 60 and 90 minutes postdose

volume of distribution

时间窗: predose and at 1, 3, 5, 7, 9, 12, 15, 20, 30, 60 and 90 minutes postdose

terminal half-life

时间窗: predose and at 1, 3, 5, 7, 9, 12, 15, 20, 30, 60 and 90 minutes postdose

amount excreted in urine

时间窗: predose and at 1, 3, 5, 7, 9, 12, 15, 20, 30, 60 and 90 minutes postdose

renal clearance

时间窗: predose and at 1, 3, 5, 7, 9, 12, 15, 20, 30, 60 and 90 minutes postdose

heart rate

时间窗: predose and at 2, 5, 8, 11, 13, 15, 17, 27 and 42 minutes postdose

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验